To evaluate the impact of intravenous ferric carboxymaltose on secondary clinical outcomes in patients with chronic heart failure and iron deficiency in the randomized, double-blind, placebo-controlled trial of 135 patients with at least NYHA class II heart failure and 1 or more iron-deficiency criteria. Participants were randomized into the intervention (n = 68) and control groups (n = 67), with a 24-week follow-up. The composite endpoint was the change in the clinical status as measured by NYHA functional class, the Kansas City Cardiomyopathy Questionnaire (KCCQ), NT-proBNP, 6-minute walking distance (6MWD), and the number of heart failure hospitalizations. Major statistically significant benefits seen in the IV iron cohort compared with placebo were NYHA functional class improvement (≥1 class: 62% vs. 31%, p < 0.001), KCCQ scores (+18.6 vs. +6.2, p < 0.001), NT-proBNP levels (−420 vs. −110 pg/mL, p < 0.001), 6MWD (+64 vs. +24 meters, p < 0.001), and fewer hospitalizations (13.2% vs. 28.4%, p = 0.032). In our studied population, the administration of intravenous iron improves very significantly clinical condition, functional capacity and biological parameters, and also helps to reduce the number of hospitalizations in patients with chronic heart failure with reduced ejection fraction and deficiency of iron. The drug was well tolerated, with no meaningful differences in adverse events between the groups.
| Mualliflar | Рахмонов Сардор Темиркул угли, Ибрагимов Хасан Исмоилович |
|---|---|
| Jurnal | Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali |
| Nashriyot | Самарқанд давлат тиббиёт университети |
| Nashr sanasi | 2025-06-06 |
| Jild | 6 |
| Son | 2 |
| Til | Ingliz |
| Ilmiy soha | Tibbiyot |
| Indeksga qo‘shilgan | 2026-08-26 |
сердечная недостаточность, дефицит железа, внутривенное железо, карбоксимальтозат железа, клинические исходы, функциональная способность, yurak yetishmovchiligi, temir tanqisligi, tomir ichiga yuboriladigan temir, karboksimaltozat temiri, klinik natijalar, funksional imkoniyat
| APA | Рахмонов Сардор Темиркул угли, & Ибрагимов Хасан Исмоилович (2025). EFFECTS OF INTRAVENOUS IRON SUPPLEMENTATION ON CLINICAL OUTCOMES IN PATIENTS WITH HEART FAILURE AND IRON DEFICIENCY. Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali, 6(2). https://www.tadqiqot.uz/index.php/cardio/article/view/11487 |
|---|---|
| GOST (OAK) | Рахмонов Сардор Темиркул угли, Ибрагимов Хасан Исмоилович EFFECTS OF INTRAVENOUS IRON SUPPLEMENTATION ON CLINICAL OUTCOMES IN PATIENTS WITH HEART FAILURE AND IRON DEFICIENCY // Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali. – 2025. – T. 6, № 2. |
| MLA | Рахмонов Сардор Темиркул угли, and Ибрагимов Хасан Исмоилович. “EFFECTS OF INTRAVENOUS IRON SUPPLEMENTATION ON CLINICAL OUTCOMES IN PATIENTS WITH HEART FAILURE AND IRON DEFICIENCY.” Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali, 6(2), 2025. https://www.tadqiqot.uz/index.php/cardio/article/view/11487 |
| Chicago | Рахмонов Сардор Темиркул угли, and Ибрагимов Хасан Исмоилович. “EFFECTS OF INTRAVENOUS IRON SUPPLEMENTATION ON CLINICAL OUTCOMES IN PATIENTS WITH HEART FAILURE AND IRON DEFICIENCY.” Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali, 6(2) (2025). https://www.tadqiqot.uz/index.php/cardio/article/view/11487 |
| Harvard | Рахмонов Сардор Темиркул угли, and Ибрагимов Хасан Исмоилович (2025) ‘EFFECTS OF INTRAVENOUS IRON SUPPLEMENTATION ON CLINICAL OUTCOMES IN PATIENTS WITH HEART FAILURE AND IRON DEFICIENCY’, Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali, 6(2). https://www.tadqiqot.uz/index.php/cardio/article/view/11487 |
| BibTeX | @article{article2025,
title = {EFFECTS OF INTRAVENOUS IRON SUPPLEMENTATION ON CLINICAL OUTCOMES IN PATIENTS WITH HEART FAILURE AND IRON DEFICIENCY},
author = {Рахмонов Сардор Темиркул угли and Ибрагимов Хасан Исмоилович},
journal = {Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali},
year = {2025},
volume = {6},
number = {2},
url = {https://www.tadqiqot.uz/index.php/cardio/article/view/11487}
} |
Boshqa maqola uchun iqtibos tayyorlash
Hypertension in the elderly is a serious medical problem that requires attention, as it increases the risk of developing many diseases that worsen the quality of life. With age, blood vessels become stiffer and less…
Arterial hypertension (AH) is one of the main factors in the development of chronic heart failure (CHF), associated with impaired left ventricular (LV) diastolic function. The purpose of the study was to evaluate the…
This study aims to investigate the problem of hypertension in pregnancy (HG)directed. 200 pregnant women in Samarkand, Uzbekistan participated in the study. In this study, 25% of the participants were diagnosed with…
Introduction. Acute myocardial infarction (AMI) is one of the leading causes of death worldwide, and its combination with atrial fibrillation (AF) significantly aggravates the course of the disease and increases the…
The study demonstrated a significant contribution to the development of acute forms of coronary heart disease, such as age, physical inactivity, chronic liver disease, and in men - tobacco use, dyslipidemia…
In our study, we studied a total of 54 patients with gout. Among them, 36 patients (72%) had arterial hypertension. In our study, patients were divided into 2 large groups according to the course of gout: patients with…
Cardiovascular diseases (CVD) remain one of the leading causes of mortality and disability among women over 40 years old. In recent decades, there has been an increase in comorbid conditions, among which metabolic…
The problem of kidney dysfunction and its impact on outcomes in different groups of cardiac patients continue to being widely used. Kidney dysfunction is associated with a number of traditional cardiovascular risk…
It is known that the main component of the prevention of cardiovascular events in patients after myocardial infarction is dual antiplatelet therapy (DAPT) The aim of the research was to study the effect of obesity…
Purpose of the research. Conduct an analysis of modern epidemiological risk factors for the realization of latent tuberculosis infection into local forms of tuberculosis in children living in tuberculosis infection…
Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali — barcha maqolalar · 2025-yil arxivi
Настоящее исследование посвящено разработке алгоритма раннего выявления сенсоневральной тугоухости у детей с использованием методов полимеразной цепной реакции (ПЦР). Обследовано 235 детей с нарушениями слуха, из…
В статье представлены клинические аспекты и диагностические проблемы выявления сенсоневральной тугоухости у новорождённых с перинатальной патологией. Обследовано 115 новорождённых, из которых 35 перенесли асфиксию, а у…
Сенсоневральная тугоухость (СНТ) у детей остаётся одной из наиболее актуальных проблем современной оториноларингологии и медицинской генетики. Ранняя диагностика нарушений слуха играет ключевую роль в предупреждении…
Сенсоневральная тугоухость у новорождённых является одной из ведущих причин нарушения слухоречевого развития и ранней инвалидизации. Наиболее уязвимыми считаются дети, перенёсшие перинатальные осложнения, такие как…
Mazkur eksperimental tadqiqotda yuqori yog‘li ratsion va seftriaksonning lipid hamda uglevod almashinuviga alohida va birgalikdagi ta’siri 160 ta oq zotsiz erkak kalamushda o‘rganildi. Tajriba hayvonlari to‘rtta guruhga…
Мазкур тадқиқотда Тошкет вилоятидаги Ўрта Чирчиқ тумани 25-сонли, Бўка тумани 3-сонли ва 9-сонли давлат мактабгача таълим ташкилотларида 2025 йил ёз мавсумидаги таомномаларнинг озиқ-овқат маҳсулотлари билан…